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Flavin Reductase Contributes 
to Pneumococcal Virulence by 
Protecting from Oxidative Stress 
and Mediating Adhesion and Elicits 
Protection Against Pneumococcal 
Challenge
Giora I. Morozov1, Nurith Porat1,2, Tatyana Kushnir1, Hastyar Najmuldeen3,4, Asad Adawi1, 
Vered Chalifa-Caspi5, Rachel Benisty1,2, Ariel Ohayon1, Ofir Liron6, Shalhevet Azriel1,  
Itai Malka1, Shahar Dotan6, Maxim Portnoi6, Andrew A. Piotrowski7, Daniel Kafka6,  
Barak Hajaj1,2, Tali Fishilevich1, Marilou Shagan1, Michael Tal6, Ron Ellis6, Donald A. Morrison7, 
Andrea M. Mitchell8, Timothy J. Mitchell8, Ron Dagan9, Hasan Yesilkaya3 &  
Yaffa Mizrachi Nebenzahl1
Pneumococcal flavin reductase (FlaR) is known to be cell-wall associated and possess age dependent 
antigenicity in children. This study aimed at characterizing FlaR and elucidating its involvement in 
pneumococcal physiology and virulence. Bioinformatic analysis of FlaR sequence identified three-
conserved cysteine residues, suggesting a transition metal-binding capacity. Recombinant FlaR 
(rFlaR) bound Fe2+ and exhibited FAD-dependent NADP-reductase activity, which increased in the 
presence of cysteine or excess Fe2+ and inhibited by divalent-chelating agents. flaR mutant was highly 
susceptible to H2O2 compared to its wild type (WT) and complemented strains, suggesting a role for 
FlaR in pneumococcal oxidative stress resistance. Additionally, flaR mutant demonstrated significantly 
decreased mice mortality following intraperitoneal infection. Interestingly, lack of FlaR did not affect 
the extent of phagocytosis by primary mouse peritoneal macrophages but reduced adhesion to A549 
cells compared to the WT and complemented strains. Noteworthy are the findings that immunization 
with rFlaR elicited protection in mice against intraperitoneal lethal challenge and anti-FlaR antisera 
neutralized bacterial virulence. Taken together, FlaR’s roles in pneumococcal physiology and virulence, 
combined with its lack of significant homology to human proteins, point towards rFlaR as a vaccine 
candidate.
Streptococcus pneumoniae is an anaerobic aero-tolerant organism whose metabolism is sensitive to the presence 
of oxygen1. Both oxygen and its ultimate metabolic by-product, hydrogen peroxide2, react slowly with cellular 
macromolecules and do not exert prominent destructive effects3. However, interaction of H2O2 with ferrous ions 
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(Fe2+) produces hydroxyl radicals by the Fenton reaction and these highly reactive oxygen species (ROS) are 
capable of destroying DNA, membrane lipids and proteins4–8. In contrast to Fe2+, the ferric ion (Fe3+), which is 
the stable form of iron since it is chemically inert at neutral pH, is considered non-toxic9,10. However, the reduc-
ing conditions in the cytoplasm can reduce Fe3+ to the toxic Fe2+ state. Among the reducing agents capable of 
reducing ferric iron are intracellular cysteine11, reduced FAD2 and to a lesser extent, glutathione, thioredoxin, 
NADH and NADPH6. In culture, pneumococci produce millimolar concentrations of H2O2, as part of their nor-
mal metabolism12. Accordingly, S. pneumoniae is relatively resistant to the destructive effects of H2O2 and ROS 
in comparison to other bacteria13,14 even though it lacks the major H2O2-degrading enzyme, catalase15–17. Two 
membrane associated, extracellular- and intracellular- thioredoxin pathways have been described, which prevent 
damages caused by ROS molecules18,19.
Since Fe2+ may exert toxic effects through the Fenton reaction, the level of Fe2+ in all organisms is tightly con-
trolled by its binding to specific ligands2,20,21. Iron concentration in aqueous solution is extremely limited (10−8–
10−9 M) and well below the range that supports microbial growth (~10−6 M)22. Iron concentration within the host 
is further restricted (up to 10−24 M) in order to suppress the generation of toxic ROS ensuring bacteriostasis at 
potential sites of infection23. As Fe2+ is essential for many biological processes, scarcity of iron within the host has 
initiated evolutionary war between host and pathogen, where successful pathogens express various mechanisms 
for iron acquisition24. The withholding of metals, such as iron, to effectively starve pathogens of essential elements 
is referred to as “nutritional immunity” and is an important facet of the innate immune system25.
Intracellular Fe2+ in the bound state is unable to interact with H2O2 and consequently ROS production is 
prevented. In eukaryotic organisms, Fe2+ is bound to intracellular heme-containing proteins, including ferritin, 
iron–sulfur proteins and extracellular iron-binding proteins, such as transferrin and lactoferrin26. In prokary-
otes, bacterioferritin, ferritin and Dps have similar functions27–29. S. pneumoniae have been found to acquire free 
inorganic iron by the ABC transporter lipoproteins PiaA and PiuA30, Pit and SPD_160931,32. In addition S. pneu-
moniae binds host Fe2+ transporter molecules such as transferrin, lactoferrin33 and haemoglobin34 to remove and 
utilize the Fe2+ associated with these proteins. However, the full extent of pneumococcal iron acquisition systems 
and their role in pneumococcal survival and virulence is not known in detail.
In our ongoing studies, we have demonstrated an age-dependent enhancement of antibody-response to a 
group of S. pneumoniae surface protein antigens35. One of these proteins, which we have previously named pneu-
mococcal surface immunogenic protein B (PsipB)35, was recently annotated in TIGR4 as flavin reductase (FlaR) 
(WP_000580659.1). In this study, we attributed functions to FlaR in Fe2+ binding and NADP reductase activity 
and demonstrated its importance to pneumococcal resistance to H2O2. Moreover, we found that FlaR contributes 
to pneumococcal virulence not only in oxygen rich environments, but also in oxygen limited environments. In 
line with these results, we ascribe an additional function for surface-expressed FlaR as an adhesin. Finally, FlaR 
elicited protective immune response in mice against S. pneumoniae, implying it can serve as a candidate vaccine.
Results
FlaR bioinformatic analyses. To examine whether flavin reductase is ubiquitous among S. pneumoniae 
strains, the flavin reductase DNA sequence of the TIGR4 strain was compared to 29 completely sequenced 
genomes of S. pneumoniae. All 29 genomes were found to contain a highly similar locus to SP_RS 02775 [BLAST 
e-value < 10−76, >97% identity, >70% query coverage (>98% coverage in 27 of the genomes)].
A BLAST search carried out with WP_000580663.1 against all S. pneumoniae RefSeq proteins annotated as 
“flavin reductase” retrieved 63 proteins, which were subjected to multiple sequence alignment and a phylogenetic 
tree was constructed. The tree was used to select a representative set of 9 divergent proteins, one from each clade 
of the tree (Supplementary Fig. S1). The position of a conserved flavin reductase domain is indicated, as well as 
three positions of conserved cysteines (equivalent to positions 66, 72 and 84 of WP_000580663.1). It is worth 
noting that cysteine was present in the three conserved positions in all 63 proteins, except 3 cases of substitution 
to tyrosine in the first or second position (data not shown).
A BLASTP search of WP_000580663.1 vs. RefSeq proteins excluding S. pneumoniae showed highly similar 
hits from other Streptococci species (e value < 10−22, 36–87% identify, query coverage >79%). Significant hits 
were also received from a wide range of non-Streptococci species (minimal e value was 10−28), however none 
had a higher a percent identity than 39%. Using an e value cutoff of 0.001, no eukaryotic proteins were retrieved.
Recombinant FlaR protein production. rFlaR was overexpressed as HAT-tagged in Escherichia coli and 
purified under denaturing conditions. The theoretical molecular weight of the untagged protein was found to be 
17.2 kDa. Separation of the HAT-tagged protein on reducing SDS-PAGE revealed a major band of 22 kDa and a 
minor band of 45 kDa (Fig. 1a). Non-reducing SDS-PAGE revealed the 45 kDa band to be the major band and 
22 kDa to be the minor one (Fig. 1a). To identify the upper and lower bands were subjected to MALDI-TOF. 
Fourteen peptides, 9 derived from in-gel digestion of the lower band and 5 from the upper band, matched the 
database sequence of a hypothetical protein from S. pneumoniae R6 strain that is homologous to FlaR in the 
TIGR4 strain. The apparent molecular weight of the upper band was approximately double than that of the lower 
one, indicating that the upper band corresponds to a dimer of the lower band. Moreover, polyclonal antibodies, 
raised in rabbits against rFlaR, detected both bands by immunoblotting (Fig. 1b), none of which were detected 
by pre-immune sera.
FlaR cellular localization. To validate the previous finding regarding the presence of FlaR on the bacterial 
surface35, we performed flow cytometry analysis on live R6 strain probed with a polyclonal mouse anti-rFlaR 
antibody. Indeed FlaR was found to be surface expressed (Fig. 1c). In addition, polyclonal rabbit antiserum rec-
ognized FlaR in the cytoplasm of WU2 WT strain in two forms: at ~17 kDa (untagged rFlaR monomer) and 
34 kDa (untagged dimer; Fig. 1d). The 34 kDa band could also be observed in the bacterial cell-wall (CW) fraction 
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(Fig. 1d) in accordance with our previous study35. A third, nonspecific band (~ 50kDa) was detected in the immu-
noblots of both the WU2 WT and WU2ΔflaRkan null mutant strains (Supplementary Fig. S2). The cytoplasmic 
protein, malonyl-CoA:ACP transacylase (FabD), which is involved in lipid metabolism36, was used as control for 
successful separation between CW and cytoplasmic fractions. FabD could be visualized (33 kDa) in both the total 
bacterial protein extract and the cytoplasm, but not in the CW fraction. This was lately described in Mizrachi 
Nebenzahl et al. 201637.
Refolding and Solubilization of rFlaR. The rFlaR was insoluble under physiological conditions and its 
purification could be obtained under denaturing conditions in buffer supplemented with 8 M urea. Different 
refolding conditions were tested for their ability to renature the protein. Dialysis of the denatured protein against 
buffers at different pH levels revealed that rFlaR could be solubilized at pH ≥ 8.0 (Fig. 2a). The presence of 
cysteine-rich sequence suggests that the protein has a transitional metal-binding ability38. Thus, rFlaR was dia-
lyzed against PBS (pH 7.3) supplemented with 2 mM salts of either transition metal or calcium and magnesium 
(2 mM of each). rFlaR became fully soluble in the presence of 2 mM FeSO4. Partial solubility could be obtained in 
the presence of 2 mM CoCl2 or CuSO4 (Fig. 2b).
FlaR is a Fe2+-binding protein. To further verify that rFlaR can directly bind Fe2+, solubilized rFlaR was 
incubated with ferrozine in the presence of free Fe2+ ions. Ferrozine is well known as an effective chelator of 
Fe2+ forming a complex that peaks at 562 nm39. During the experiment the absorbance was significantly lower 
Figure 1. Expression of recombinant Flavin reductase (rFlaR). (a) rFlaR was purified using Ni-NTA 
beads under denaturing conditions and resolved by SDS-PAGE using sample buffer with or without 
β-mercaptoethanol (β-ME). (b) rFlaR was separated using SDS-PAGE. The protein was transferred to a 
nitrocellulose membrane and probed with rabbit antiserum raised against rFlaR (lane 1) or preimmune rabbit 
serum (lane 2). (c) Expression of FlaR on the surface of R6 was detected by flow cytometry using mouse anti-
rFlaR antibodies. (d) Cytoplasmic (cyto) and cell wall (CW) fractions prepared from WU2 were subjected 
to electrophoresis and immunoblotted with rabbit anti-rFlaR antiserum. Of note, this gel was cropped from 
Supplementary Fig. S2.
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in solutions containing rFlaR, solubilized either at pH 8 or with 2 mM Fe2+, in comparison to three different 
controls supplemented with 2 mM Fe2+: 1) PBS (Fig. 3; Control; p = 0.0001); 2) PBS supplemented with bovine 
serum albumin (BSA) and 3) PBS supplemented with pneumococcal protein aspartate carbomoyltransferase 
(WP_001293838.1; ATCase)37, not known to bind Fe2+. As a positive control for Fe2+ binding, we have used eth-
ylenediaminetetraacetic acid (EDTA; 10 nM), which significantly inhibited the ferrozine-iron interaction (Fig. 3, 
p = 0.0001). The ability of rFlaR to compete with ferrozine for Fe2+ binding points out that FlaR is a Fe2+ binding 
protein.
rFlaR has NADP reductase activity. Flavin-binding domains are found in proteins with oxidoreductase 
activity. Nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) is used as an electron donor in the enzy-
matic reactions of flavin reductases38–40. To test whether rFlaR is involved in flavin-dependent redox reactions, we 
performed a flavin reductase activity assay as previously described40,41. Oxidation of NADPH, measured at A340 
Figure 2. Refolding of rFlaR. (a) rFlaR was eluted from a Ni-NTA column under denaturing conditions and 
dialyzed against a buffer containing 0.1% SDS. The solution was then dialyzed against: lane 1, 20 mM acetate 
pH 5.0; lane 2, 20 mM MES pH 6.0; lane 3, 20 mM phosphate pH 7.0; lane 4, 20 mM phosphate pH 8.0; lane 5, 
20 mM Tris pH 9.0. All buffers contained 150 mM NaCl. Lane 6, rFlaR before dialysis. The dialyzed solution 
was resolved on 1D SDS-PAGE and stained with Coomassie Brilliant Blue. (b) rFlaR, solubilized with buffer 
containing 0.1% SDS, was dialyzed against PBS containing 2 mM of the following metal salts: lane 1, rFlaR 
before dialysis; lane 2, 2mM MnCl2, lane 3, 2mM  FeSO4, lane 4, 2mM CoCl2, lane 5, 2mM NiCl2, lane 6, 
2mM CuSO4, lane 7, 2mM ZnCl2, lane 8, 2mM MgCl2 and 2mM CaCl2. The dialyzed solution was resolved on 
1D SDS-PAGE and stained with Coomassie Brilliant Blue.
Figure 3. Iron binding by FlaR. The extent of Fe2+ staining by ferrozine was monitored in iron ammonium 
sulfate solution in PBS (control), PBS supplemented with BSA (BSA), PBS supplemented with rATCase 
(rATCase), EDTA, rFlaR refolded at pH 8.0 (rFlaR (pH 8.0)) and rFlaR refolded in the presence Fe2+ iron ions 
(Fe2+). The results presented are the mean of three different experiments (one way ANOVA with Dunnett’s post 
hoc multiple comparisons test, n = 3 in each group, ****p = 0.0001).
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nm, could not be observed in the presence of iron-refolded rFlaR and flavin adenine dinucleotide (FAD) (data not 
shown). Significant increase in the reduction of NADP mediated by rFlaR was observed only in the presence of all 
the reaction components (NADP and FAD) over time (Fig. 4a, Spearman correlation, r = 1, p = 0.0014). No sig-
nificant NADP reduction could be observed in the absence of either one of the components (Fig. 4a, p = 0.0001). 
After the first hour of the reaction in the presence Fe2+ and rFlaR, the absorbance change at 340 nm was 0.09, 
equivalent to 14.5 µM/hour of generated NADPH (calculated by using ε 6.22 mM−1 cm−1)42,43. Hence, rFlaR spe-
cific activity is 40.3 µM min−1 mg−1 protein. It should be noted that iron-refolded rFlaR exhibited significantly 
higher NADP-reductase activity compared to rFlaR refolded at pH 8.0 in the absence of Fe2+ ions. BSA was used 
as a negative control (Fig. 4b, p = 0.0001). The NADP reductase activity of rFlaR refolded at pH 8.0 was still sig-
nificantly higher in comparison to the negative control (Fig. 4b, p = 0.02).
rFlaR NADP reductase activity is Fe2+ dependent. To evaluate the importance of Fe2+ for rFlaR 
enzymatic activity, different divalent ion chelators were introduced into the reaction mixture. EDTA (10 nM), 
Nitrilotriacetic acid (NTA; 10 nM) and citrate (10 nM) all significantly inhibited rFlaR NADP reductase activity 
(Fig. 5a; p = 0.0001). To rule out the possibility that Fe2+ is oxidized by H2O2, NADP reductase activity was meas-
ured in the presence of the H2O2 scavenger, salicylate. Indeed, salicylate did not inhibit NADPH production by 
rFlaR (Fig. 5b), indicating that H2O2 does not affect FlaR activity directly.
Fe2+ is the electron donor in the rFlaR-NADP reductase activity. The next step was to determine the 
electron donor in rFlaR reductase activity. When cysteine was used as a reducing agent, the rFlaR FAD-dependent 
NADP reduction was enhanced in a concentration-dependent manner (Fig. 6a, Spearman correlation, r = 1, 
p = 0.0083). To detect which component in the reaction mixture was reduced cysteine was applied to solutions 
containing either ammonium iron sulfate, or FAD or NADP. Ammonium iron sulfate incubated for 2 hours at 
room temperature was found to be significantly oxidized (Fig. 6b, p = 0.0001). Addition of cysteine reduced the 
oxidized Fe3+ to Fe2+, as detected by the ferrozine stain (Fig. 6b; p = 0.0001). Both NADP and FAD were tested 
in their oxidized forms and no reduction in NADP and FAD could be observed in the presence of cysteine. These 
findings suggest that the stimulation of rFlaR activity occurs through the recycling of Fe3+ to Fe2+ by cysteine. To 
verify this point, excess Fe2+ ions were supplemented into the reaction mixture containing rFlaR, FAD and NADP. 
Indeed, rFlaR NADP reductase activity was stimulated in the presence of Fe2+ in a concentration-dependent 
manner (Fig. 6c, Pearson correlation, r = 0.9947, p < 0.0001).
FlaR contributes S. pneumoniae resistance under oxidative stress conditions. To determine the 
importance of FlaR to S. pneumoniae resistance to oxidative stress, flaR null mutant (WU2ΔflaRErm) and com-
plemented strains (WU2ΔflaRflaR/Erm/Kan plasmid and WU2ΔflaRflaR/Erm/Kan chromosome) were constructed as 
Figure 4. NADP-reductase activity of rFlaR. (a) A significant reduction of NADP by rFlaR refolded in the 
presence Fe2+ was measured over a period of 16 hours at A340 at the presence of FAD (Spearman correlation, 
r = 1, **p = 0.0014). The reaction mixtures without individual components (w/o rFlaR, w/o FAD, w/o NADP) 
served as controls and no redox activity could be detected (whole graph comparisons using one way ANOVA 
with Dunnett’s post hoc test, ****p = 0.0001). (b) NADP-reductase activities of rFlaR refolded at the presence 
(rFlaR (Fe2+)) and rFlaR refolded at pH 8.0 (rFlaR (pH 8)) at the absence of Fe2+ were compared. In the control 
reaction mixture rFlaR was replaced with BSA. The difference between the absorbance at 340 nm after 90 min 
incubation and the absorbance at 340 nm at time 0 (Δ A340 nm) was calculated. The results presented are the 
mean of three different experiments (one way ANOVA with Dunnett’s Post Hoc multiple comparisons test, 
n = 3 in each group, *p = 0.02; ****p = 0.0001).
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described in the Methods section. No differences in the growth rates could be observed when WU2 WT and all 
above strains were grown in THY under anaerobic conditions (Supplementary Fig. S3). Following a challenge 
with 20 mM H2O2, significantly reduced survival of WU2ΔflaRErm was measured, 44%, compared to 93%, 92%, 
76% survival of WU2 WT, WU2ΔflaRflaR/Erm/Kan plasmid and WU2ΔflaRflaR/Erm/Kan chromosome respectively, 
(Fig. 7, p = 0.0001). These findings highlights the involvement of FlaR’s in oxidative stress resistance. However, 
chromosomal complementation did not fully restore bacterial survival under oxidative stress conditions in com-
parison to the WT (Fig. 7, p = 0.0011).
FlaR contributes to S. pneumoniae virulence. To test whether FlaR contributes to S. pneumoniae vir-
ulence, BALB/c mice were inoculated intraperitoneally (IP) with WU2 WT or WU2ΔflaRKan strains. Increased 
survival was observed in mice inoculated with WU2ΔflaRKan compared to inoculation with the WT WU2, 
though it did not reach statistical significance (Fig. 8a). In an attempt to increase signal-to-noise responses, IP 
inoculation was performed using CBA/CaHN-Btkxid/J mice (CBA/Nxid). This mouse strain carries a mutation 
in the Bruton kinase (btk) gene that renders it highly susceptible to S. pneumoniae infection44,45. Significantly 
increased survival rates were observed in CBA/Nxid mice inoculated IP with WU2ΔflaRKan compared to mice 
inoculated with WU2 WT (Fig. 8b, p = 0.0236).
Mechanisms underlying FlaR contribution to S. pneumoniae virulence. The reduced virulence in 
the peritoneum in the absence of FlaR may result from two different mechanisms: increased sensitivity to oxi-
dative stress elicited by immune cells or reduced adhesion and spread in the host. To test the first possibility, the 
extent of phagocytosis of WU2 WT, WU2ΔflaRErm and WU2ΔflaRflaR/Erm/Kan complemented strains was evalu-
ated. Interestingly, no significant differences in the phagocytosis by primary mice macrophages were observed 
for all of these strains (Fig. 9a, p = 0.1190). These data suggest that the reduced pneumococcal virulence in the 
peritoneum in the absence of FlaR is not due to increased sensitivity to oxidative stress produced by the recruited 
immune cells. This is in accordance with data published recently, showing that oxidation is not the major killing 
mechanism of S. pneumoniae by phagocytic cells46.
The surface expression of FlaR, presented in the previous35 and the current studies (Fig. 1), encouraged testing 
the second mechanism of FlaR involvement in virulence i.e adhesion. As demonstrated in Fig. 9b, WU2ΔflaRErm 
mutant adhesion to lung-derived epithelial (A549) cells was significantly reduced compared to the WU2 WT 
(~76%; Fig. 9, p = 0.0001), WU2ΔflaRflaR/Erm/Kan plasmid (~73%, p = 0.0001) and WU2ΔflaRflaR/Erm/Kan chromo-
some (~64%, p = 0.0001). Complementation in WU2ΔflaRflaR/Erm/Kan plasmid restored bacterial adhesion to A549 
cells to about 88%, not significantly differing from the WU2 WT. The adhesion of WU2ΔflaRflaR/Erm/Kan chro-
mosome strain was restored only up to 65%, remaining significantly lower compared to the WU2 WT (Fig. 9b, 
p = 0.0011). These data suggest that FlaR is involved in bacterial adhesion to the host cells in addition to its 
enzymatic function. Similarly, reduced adhesion to the glioblastoma cell line U25147 and the motor neuron cell 
Figure 5. Fe2+ involvement in FlaR enzymatic activity. (a) Different divalent ion chelators (EDTA (10 nM), 
NTA (10 nM) and citrate (10 nM)) introduced into rFlaR reaction mixture significantly inhibited rFlaR redox 
enzymatic activity. Results are presented as Δ A340 nm, that was calculated as described in Fig. 3 The results 
presented are the mean of three different experiments (one way ANOVA with Dunnett’s post hoc multiple 
comparisons test, n = 3 in each group, ****p = 0.0001). (b) The effect of the H2O2 on rFlaR NADP-reductase 
activity was eliminated by H2O2 scavenger, salicylate (Spearman correlation, r = −0.0513, p = 0.5 not 
significant).
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line NSC 3448 was observed with WU2ΔflaRErm in comparison to the WT and to the two complemented strains 
(data not shown).
Vaccine potential of rFlaR. The finding that FlaR contributes to S. pneumoniae virulence, combined 
with the lack of significant similarity to any human protein, directed us to test the vaccine potential of rFlaR. 
Immunization of BALB/c mice with rFlaR elicited the production anti- rFlaR antibodies. An increase in anti-
body levels could be observed following the secondary immunization however this increase reached significance 
only after the tertiary immunization. The antisera titer following the third immunization reached ~1:10000 
(Supplementary Fig S4, p = 0.014).
In addition, significant protection against IP lethal S. pneumoniae challenge was observed following immuni-
zation with rFlaR in comparison to adjuvant only immunization (Fig. 10a 15 µg rFlaR + alum, p = 0.0388; Fig. 10b 
25 µg rFlaR + alum, p = 0.0001; Fig. 10c 35 µg rFlaR + CFA/IFA, p = 0.0053). To further demonstrate rFlaR ability 
to elicit protective immune response we have performed a modified method of passive immunization. Bacteria 
were incubated ex-vivo with either pre-immune or anti-rFlaR antiserum. Mice were inoculated IP with bacte-
ria pre-treated with the anti-rFlaR antiserum survived significantly longer than mice inoculated with bacteria 
pre-treated with pre-immune serum (Fig. 10d, p < 0.0001).
Figure 6. Participation of Fe2+ in FlaR enzymatic activity. (a) Cysteine significantly stimulates rFlaR NADP-
reductase activity (Spearman correlation, r = 1, **p = 0.0083). (b) Solutions containing either 10 µM Fe2+ 
or 200 µM NADP or 50 µM FAD were incubated with cysteine. The oxidative state of Fe2+ was assessed with 
ferrozine staining and monitored at A562 nm. The oxidative state of FAD was monitored at A450 nm and that 
of NADP monitored at A340 nm. Fe2+, FAD and NADPH in aqueous solutions were allowed to oxidize for 2 
hrs, and then cysteine was added for additional 2 hrs. Oxidation was observed only in Fe2+ solution which was 
significantly reduced upon cysteine addition. The results presented are the mean of three different experiments 
(one way ANOVA with Dunnett’s post hoc multiple comparisons test, n = 3 in each group, n = 3 in each group, 
****p = 0.0001). (c) Increasing concentrations of Fe2+ significantly enhanced rFlaR NADP-reductase activity 
(Pearson correlation, r = 0.9947, ****p < 0.0001).
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Discussion
A putative flavin reductase (FlaR) was recently annotated in S. pneumoniae TIGR4 strain in the NCBI database. 
We have previously shown that there is an age-dependent enhancement of the antibody response to this protein35. 
Therefore, we initially named it pneumococcal surface immunogenic protein B (PsipB), but in order to con-
form with the NCBI database we currently refer to this protein as FlaR. FlaR was found to be surface expressed, 
although it is devoid of a signal peptide or any other known export sequences35. Several additional S. pneumoniae 
proteins such as α-enolase49,50, glyceraldehyde 3-phosphate dehydrogenase, fructose-bisphosphate aldolase35, 
glutamyl tRNA synthetase51, NOX52 and PtsA39 were also shown to be cell surface localized albeit lack of known 
export signals53,54. The current study further confirmed the cell surface localization of FlaR, using immunoblot-
ting and flow cytometry.
FlaR was found to be highly conserved in different S. pneumoniae strains. In addition, highly conserved 
cysteines at positions 66, 72 and 84 of WP_000580663.1 were found in all S. pneumoniae sequenced flavin reduc-
tases. Multiple cysteines in a protein may enable the formation of multimers. Indeed, resolving rFlaR protein on 
SDS-PAGE demonstrated the existence of both dimeric and monomeric forms of FlaR. Equilibrium between the 
dimeric and monomeric forms may be important for FlaR enzymatic activity, as hydrogenases are known to often 
function as homo-dimers55 or multi-enzyme complexes56. Moreover, multiple cysteines in a protein sequence may 
indicate a transitional metal ion binding capacity57. Metal ions can interact with metal-binding proteins during 
their folding and create a local structure that initiates and directs the protein-folding process and is considered 
critical for its biological activity58,59. In accordance, rFlaR could be refolded/solubilized at physiological pH only 
Figure 7. FlaR facilitates S. pneumoniae growth under oxidative stress. The WU2 WT, WU2ΔflaRErm and 
complemented strains WU2ΔflaRflaR/Erm/Kan plasmid and WU2ΔflaRflaR/Erm/Kan chromosome were inoculated 
into 20 ml of THY at initial OD620 = 0.05 and grown to OD620 = 0.35 under anaerobic conditions. Then, bacteria 
were harvested, resuspended in PBS and incubated with equal volumes of either PBS (control) or H2O2, at final 
concentration of 20 mM. The WU2ΔflaRErm mutant and, to a lesser extent, WU2ΔflaRflaR/Erm/Kan chromosome 
strain exhibited significant susceptibility to the oxidative stress, relative to the WU2 WT. The results presented 
are the mean of three different experiments, each performed in triplicates (one way ANOVA with Dunnett’s 
post hoc multiple comparisons test, n = 3 in each group, ** p = 0.0011; ****p = 0.0001).
Figure 8. Reduced virulence of WU2ΔflaRKan mutant. (a) Seven-week-old BALB/c mice were inoculated IP 
with 64 CFU of WU2 WT (n = 8) or 79 CFU of WU2ΔflaRKan (n = 7) and survival was monitored daily (Log-
rank (Mantel-Cox) test). (b) Seven-week-old CBA/Nxid mice were inoculated IP with 80 CFU of WU2 WT 
(n = 10) or WU2ΔflaRKan (n = 8) and survival was monitored daily (Log-rank (Mantel-Cox) test *p = 0.0236).
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in the presence of Fe2+ and to lesser extent with Co2+ and Cu2+. Noteworthy is the finding that rFlaR, refolded at 
pH 8 without Fe2+, bound Fe2+ as detected by the ferrozine stain.
We validated the putative flavin reductase activity of rFlaR and found that NADP and FAD are necessary 
components for its enzymatic activity, as described for NADPH reductases60. In contrast, the flavin reductase 
activity of ferredoxin-NADP+ reductase from Pseudomonas putida was FAD-independent42. The activity of 
NADPH-cytochrome p 450 reductase is generally accompanied by measurable alterations in FAD and FMA 
oxidative state60. Although rFlaR catalyzed NADP reduction in a FAD-dependent manner, we failed to detect the 
change in FAD oxidative state.
Refolding of rFlaR in the presence of Fe2+ enhanced its enzymatic activity in comparison to the rFlaR refolded 
at pH 8, possibly as a result of increased initial binding of Fe2+. The ability of divalent ion chelators to inhibit rFlaR 
activity reinforce Fe2+ necessity for NADP reduction by FlaR.
The midpoint potential of Fe2+ in solution, as a complex with EDTA, is +0.1 V while the midpoint potential 
of NADP is much lower (−0.32 V), rendering reduction of NADP by Fe2+ improbable. However, the midpoint 
potential of Fe2+ bound to 4Fe-4S cluster of ferredoxin from Butyribacterium methylotrophicum was found to 
be −0.410 V61 and −0.472 V in 2Fe-2S cluster of oxidoreductase from Paracoccus denitrificans62. Additionally, it 
was shown that substitution of amino acid residues around an Fe2+-sulfur cluster, by site-directed mutagenesis, 
affects the midpoint potential of the Fe2+ in the cluster63. The finding that under physiological conditions rFlaR 
remains soluble only in the presence of Fe2+, impedes determination of the midpoint potential of Fe2+ bound to 
FlaR. Yet, the demonstration of Fe2+ dependent rFlaR NADP reductase activity indicates that the FlaR-bound 
Fe2+ midpoint potential is probably lower than that of NADP.
Mucosal surfaces lack free Fe2+ due to chelation by host Fe2+ -binding proteins64. S. pneumoniae has several 
mechanisms enabling it to cope with iron deficiency, among them hijacking iron from hemin, hemoglobin or 
lactoferrin33,65, or direct iron binding by ABC iron transporters Pit1B and Pit2A31. A double mutant of pit1B 
and pit2A demonstrated growth deficiency in a cation-depleted medium, which was restored by the addition of 
Fe2+ 31. In addition, the 12 mer Dpr/Dps that bind, oxidize and store ~500 Fe2+ atoms in its hollow cavity has been 
identified in streptococci27,66. The current study revealed that FlaR belongs to the Fe2+ binding proteins.
rFlaR activity was found to be enhanced in the presence of increasing concentration of the reducing agent, 
cysteine. Our demonstration that cysteine reduced Fe3+ but not FAD or NADP, implies that the increase in 
NADPH in the presence of cysteine stemmed from Fe3+ to Fe2+ recycling, which stimulated rFlaR activity. In 
line is the finding that rFlaR NADP reductase activity was enhanced in a Fe2+ concentration-dependent manner.
Tight regulation of the free Fe2+ pool can be especially important for pneumococci, which produce high levels 
of H2O2 but lack catalase, and hence are at high risk of damage by ROS formed via the Fenton reaction13. We 
hypothesized that FlaR is involved in preventing the accumulation of toxic levels of free Fe2+ that may react with 
Figure 9. Mechanisms underlying FlaR contribution to S. pneumoniae virulence. (a) Phagocytosis assay. Mice 
peritoneal cells were plated onto 96 well culture plates (2 × 105 cells/well). Adherent cells were incubated with 
either WU2 WT, WU2ΔflaRErm or WU2ΔflaRflaR/Erm/Kan complemented strains (2.5 × 104 CFU/well) for 40 min. 
Aliquots of the supernatant were plated onto blood agar plates for enumeration. The number of phagocytosed 
bacteria is presented as the difference between initial bacterial CFU/well and the residual live bacteria CFU/
well. Presented here is the summary of 2 biological independent experiments each performed in triplicates 
(One-way ANOVA, p = 0.1190, non-significant). (b) FlaR mediates bacterial adhesion to host cells. The WU2 
WT, WU2ΔflaRErm and complemented WU2ΔflaRflaR/Erm/Kan plasmid and WU2ΔflaRflaR/Erm/Kan chromosome 
strains (MOI 10:1) were added to A549 cells, cultured in 96 well plates for 1 h at 37 °C. Excess bacteria were 
then removed, cells released with 0.25% trypsin-EDTA and plated onto blood agar plates for enumeration. The 
WU2ΔflaRErm mutant and, to a lesser extent, WU2ΔflaRflaR/Erm/Kan chromosome strain exhibited significant 
inhibition of adhesion, relative to the WU2 WT and to the WU2ΔflaRflaR/Erm/Kan plasmid. The experiment was 
repeated three times on different occasions. Results presented here is of a representative experiment performed 
in quadruplicates (one way ANOVA with Dunnett’s post hoc multiple comparisons test, n = 4 in each group, 
*p = 0.0103; ***p < 0.0004; ****p = 0.0001).
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H2O2 and produce ROS. Indeed, WU2ΔflaR demonstrated marked susceptibility to H2O2 and complementation 
restored bacterial resistance to H2O2. Of note, the strain complemented with the plasmid demonstrated increased 
resistance to H2O2 in comparison to the strain complemented in chromosome. The explanation may be that fol-
lowing flaR trans-complementation, multi-copies of flaR are expressed, whereas following cis-complementation 
(into the same chromosome) a single copy of flaR is expressed, under the control of its native promoter. This may 
stem from two concomitantly occurring mechanisms: i) FlaR’s function in binding and oxidizing Fe2+ to protect 
the bacterium from the toxic effects of the Fenton reaction; ii) FlaR’s NADP reductase activity provides an addi-
tional source of NAD(P)H beside the Embden-Meyerhof-Parnas and the pentose phosphate pathways. Increased 
NAD(P)H levels are essential under high H2O2 levels for NADH oxidase activity67. The action of NADH oxidase 
makes pyruvate available for SpxB oxidation, resulting in the production of two additional ATP molecules per 
one glucose molecule, beyond that available from conventional glycolysis13,68. Moreover, the electron transport 
to NADPH by FlaR enzymatic activity may increase the reduction of cysteine containing enzymes69 to maintain 
redox balance thus enhancing bacterial growth and virulence70.
In contrast to our finding that the presence of FlaR in the cells confer resistance to oxidative stress, Pericone 
et al.13 claimed that iron chelators had no effect on the survival of WT or a mutant lacking pyruvate oxidase 
(ΔspxB) following a challenge with 20 mM H2O2. This led the authors to suggest that the Fenton reaction does 
not play a major role in the killing of S. pneumoniae by H2O2. The mechanism by which FlaR contributes to 
bacterial survival under oxidative stress conditions should be further elucidated. Of note is the finding that Fe2+ 
dependent-rFlaR activity was not affected by the H2O2 scavenger, salicylate, suggesting that Fe2+ oxidation is not 
directly executed by H2O2.
The contribution of FlaR to pneumococcal virulence was tested in a mouse model of sepsis. The reduced vir-
ulence of S. pneumoniae in the peritoneum, in the absence of FlaR, could be explained by increased sensitivity to 
phagocytosis and oxidative stress elicited by immune cells. The phagocytic role of macrophages in S. pneumoniae 
engulfment and killing has been previously demonstrated for bronchoalveolar lavage derived macrophages71, 
peritoneal macrophages72 and neutrophils46,73. Interestingly, we found that FlaR absence did not significantly 
affect the extent of phagocytosis by primary mice peritoneal macrophages. In line, in vitro studies demonstrated 
that the predominant killing mechanism of pneumococci in the phagosome of neutrophils is executed by the 
proteolytic activity of two serine proteases rather than oxidation46,73. The involvement of the serine proteases in 
pneumococcal killing was further confirmed in vivo demonstrating higher bacterial load in the spleen of mice 
lacking the serine proteases in a systemic infection model46. These authors also emphasized that in the case of 
Figure 10. Vaccine potential of rFlaR. Immunization of BALB/c mice with rFlaR conferred significant 
protection against IP lethal S. pneumoniae challenge. (a) 15 µg (Log-rank (Mantel-Cox) test, n = 7 in the control 
and n = 17 in the immunized group, *p = 0.0388) and (b) 25 µg rFlaR in the presence of alum as an adjuvant and 
(Log-rank (Mantel-Cox) test, n = 7 in the control and n = 17 in the immunized group,***p = 0.0001) (c). 35 µg 
rFlaR using CFA in primary immunization and IFA in booster immunizations (Log-rank (Mantel-Cox) test, 
n = 19 in the control and n = 14 in the immunized group,**p = 0.0053). (d) BALB/c mice inoculated IP with 
WU2 WT treated with anti-rFlaR antiserum obtained from immunized rabbits survived significantly longer 
then mice inoculated with WU2 WT treated ex-vivo with preimmune serum (Log-rank (Mantel-Cox) test, 
n = 10 in the control and n = 10 in the immunized group, ****p < 0.0001).
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systemic infection with S. pneumoniae, most of the bacteria can be found in the spleen and to a lesser extent in 
other organs46.
The peritoneum is characterized by low oxygen pressure74. Thus, the role of FlaR in protection against oxida-
tive stress could not explain the reduced virulence of WU2ΔflaRkan in this niche suggesting an additional role 
for FlaR in virulence. FlaR was found to be surface expressed using immunoblotting of cell-wall proteins and 
flow cytometry. Pre-incubation of S. pneumoniae with anti-FlaR antisera, which interacts only with the surface 
exposed FlaR, reduced bacterial virulence, reinforcing the surface localization of FlaR. Many surface proteins 
were found to mediate bacterial adhesion to the host37. Hence, we hypothesized that FlaR may be involved in 
bacterial adhesion to host cells. Indeed, WU2ΔflaRErm strain was found to adhere to A549 cells significantly less 
than its parental WT and the two complemented strains. We have also used glioblastoma cells U25147 and motor 
neuron cells NSC3448 to establish FlaR contribution to S. pneumoniae adhesion and similar results were obtained. 
The ability of anti-rFlaR antibodies to reduce bacterial virulence also implies a direct involvement of the surface 
expressed FlaR in virulence and diminishes the possibility that downstream consequences of the mutation, such 
as upregulation of other adhesins, are responsible for the bacterial virulence.
The following findings highlight FlaR as a potential candidate vaccine: 1) possesses age dependent antigenic-
ity; 2) is conserved among S. pneumoniae strains; 3) lacks significant homology to human proteins; 4) protects the 
bacterium against oxidative stress and 5) possibly mediates S. pneumoniae adhesion to the host. Indeed, FlaR elic-
ited significant protection against IP challenge. In addition, sera obtained from immunized rabbits were able to 
neutralize S. pneumoniae virulence in the peritoneum, probably by enhancing opsonophagocytosis and/or inter-
fering with bacterial adhesion and spread. Hence, rFlaR can be considered as a future vaccine candidate. It should 
be noted that proteins, such as PspA, CbpA, PavA, PavB and PhtD, which are involved in different aspects of 
bacterial virulence including adhesion, are known to be immunogenic and to elicit a protective immune response 
in experimental infection models75–79. Furthermore, PhtD has recently been shown to elicit an immune response 
in phase I/II clinical trials80,81.
In summary, this study attributes FlaR multiple functions in S. pneumoniae physiology and virulence: i) Fe2+ 
binding and oxidizing to prevent the toxic effect of the Fenton reaction; ii) reducing NADP to provides an addi-
tional source of NAD(P)H, resulting in maintenance of redox balance and ATP production; and iii) mediating 
bacterial adhesion to the host. Importantly, we found that rFlaR can be considered for future vaccine develop-
ment. Further studies should concentrate on detailed understanding of FlaR’s role in pneumococcal biology and 
the nature of the immune protection elicited by FlaR.
Methods
Inoculation and immunization of mice and ethics statements. This study was carried out in strict 
accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National 
Institutes of Health. The protocol was approved by the Institutional Animal Care and Use Committee of the Ben-
Gurion University of the Negev, Beer Sheva, Israel (Permit number: 53.08.08).
Seven-week-old BALB/cOlaHsd (BALB/c) female mice (Harlan Laboratories, Israel) or seven-week-old CBA/
CaHN-Btkxid (CBA/Nxid; Jackson Laboratories, Bar Harbor, ME, USA) mice were housed in sterile conditions 
under 12-h light/dark cycles and fed Purina Chow and tap water ad libitum. The groups were matched for age.
BALB/c mice were inoculated IP (without anesthesia) with the WU2 WT (n = 8; 64 CFU) or WU2ΔflaRKan 
(n = 7; 64 CFU) strains. Survival was monitored daily. Additionally, CBA/Nxid mice were inoculated IP (without 
anesthesia) with WU2 WT (n = 10; 80 CFU) or WU2ΔflaRKan (n = 8; 80 CFU), and survival was monitored daily.
BALB/c mice were immunized subcutaneously with 15 µg rFlaR (rFlaR + alum n = 17; alum n = 7) or 25 µg 
rFlaR (rFlaR + alum n = 17; alum n = 7) mixed with 75 µl of the Imject Alum adjuvant (Pierce Biotechnology, 
Inc., Rockford, IL) or 35 µg rFlaR emulsified with complete Freud’s adjuvant (CFA) on primary immunization and 
boosted (days 14 and 28) with rFlaR emulsified with incomplete Freud’s adjuvant (IFA) (rFlaR + CFA/IFA n = 19; 
CFA/IFA only, n = 14). Mice were challenged IP on day 42, under deep anesthesia using isoflurane (Piramal 
Critical Care Inc., PA, USA) with a lethal dose of WU2 WT strain (~102 CFU).
Ex-vivo neutralization was performed as follows: a lethal dose (~102 CFU) of WU2 WT strain was incubated 
at 37 °C for 1 hour with 1:10 diluted rabbit pre-immune serum or anti-rFlaR serum and subsequently inoculated 
IP to BALB/c mice (n = 10 in each group). Survival was monitored daily.
For all animal experiments, mice were humanely euthanized by CO2 asphyxiation, as recommended by the 
American Veterinary Medical Association (AVMA) guidelines for euthanasia 2013, if they became moribund or 
showed evidence of distress. The following criteria were considered sufficient evidence of distress to warrant such 
intervention in order to minimize pain and suffering to animals: severe weight loss (20% body weight); reluctance 
or inability to move freely; appearance of bristle fur; social disengagement; refusal or inability to eat or drink. No 
analgesic treatment was provided as such treatment may alter the immune response and may independently affect 
the outcome of the experiments82.
Chemicals and Biological Reagents. Unless otherwise stated, all chemicals and biochemicals of highest 
purity available were purchased from Sigma-Aldrich Corp. (St Louis, MO). FAD and NADP were purchased from 
Applicheme GmbH (Darmstadt, Germany). For research involving biohazards, correct standard procedures have 
been carried out.
Bacterial Strains and Growth Media. S. pneumoniae serotype 3 strain WU244 and its derivatives, 
described below, were used. Pneumococci were grown on blood agar plates or in Todd-Hewitt broth supple-
mented with 0.5% (w/v) yeast extract (THY). Two Escherichia coli strains, DH5α UltraMAX (DH5α; Invitrogen 
Corp, Carlsbad, CA, USA) and E. coli BL21(DE3)pLysS (BL21; Promega Corp, Madison, WI), were grown in 
Luria broth (LB), Lennox.
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Cloning, Expression and Purification of rFlaR, rFabD, rATCase and antibodies production. The 
flaR gene was amplified from S. pneumoniae strain WU2 genomic DNA by PCR using the primers FlaR-F and 
FlaR-R (Supplementary Table S1, flaR pHAT expression) designed according to the sequence in the R6 strain 
(spr0489). The amplified and BamHI-SacI (Takara Bio Inc, Shiga, Japan)-digested DNA-fragments were cloned 
into the pHAT expression vector (BD Biosciences Clontech, Palo Alto, CA) and transformed into DH5α E. coli 
cells. The vector was purified using the Qiagen High Speed Plasmid Maxi Kit (Qiagen GMBH, Hilden, Germany) 
and transformed into E. coli BL21. Sequencing was performed to rule out any mutation. rFlaR expression was 
induced by incubation for 5 h with 1 mM of IPTG at 37 °C. The protein was purified under denaturing conditions 
using Ni-NTA agarose beads (Qiagen GMBH). This preparation was dialyzed against PBS pH 7.3, containing 
2 mM FeSO4 for 48 h with three changes of buffer (named rFlaR Fe2+). Isolation of the protein was confirmed by 
immunoblotting with anti-HAT (BD Biosciences Clontech) and thereafter with anti-rFlaR antibodies (described 
below) and trypsin in-gel digestion of the protein to derive peptides for MALDI-TOF mass spectrometry 
sequencing (Bruker Reflex-IV mass spectrometer Bruker-Daltonik, Bremen, Germany). Alignment to existing 
databases was performed using both the Mascot software package (Matrix Science Ltd., UK, http://www.matrix-
science.com) and the “Profound” Program provided by the Rockefeller University.
Refolding of rFlaR was performed using 20 mM of the following buffers: Acetate pH 5.0, 2-(N-morpholino)
ethanesulfonic acid (MES), pH 6.0, phosphate pH 7.0 and pH 8.0, tris(hydroxymethyl)aminomethane pH 9.
Untagged protein was produced by amplifying the gene using the S. pneumoniae TIGR4 strain (ATCC, 
Rockville, MD, USA) DNA as template, using specific primers (Supplementary Table S1, flaR pET30a (+)). 
Digestion of pET30a(+) (Novagen, Madison, WI, USA) with NdeI and Bpu1102I restriction enzymes, prior to 
ligation removed all tags from the vector. Then, flaR was cloned into the vector. Protein expression was induced 
with IPTG in fermented E. coli BL21 followed by inclusion bodies isolation. The inclusion bodies were centrifuged 
and resuspended in double distilled water and frozen in aliquots. The inclusion bodies were refolded by dialysis 
for 1 hour against a buffer adjusted to pH 11.3, containing 4.5 M urea, 40 mM Tris base and 1 mM cysteine, fol-
lowed by the addition of 0.67 mM arginine and continued dialysis overnight. The resulting solution was concen-
trated ~4.4 fold. This preparation was applied to a preparative Superdex 200 column and elution was performed 
with buffer adjusted to pH 10, containing 4.5 M urea, 40 mM Tris base and 1 mM cysteine. The tubes containing 
the protein were pooled and dialyzed against NaHCO3 at pH 11 followed by lyophilization. The lyophilized pro-
tein was suspended in PBS pH 8 (named FlaR pH 8).
For antibodies production, three-month-old New Zealand white rabbits and 7-week old BALB/c mice were 
immunized with Ni-NTA-purified rFlaR formulated with CFA in the first immunization and IFA in the two 
booster immunization with two-week intervals between immunizations. The rabbits were bled following the third 
immunization.
FabD was cloned and expressed as a His-tagged soluble protein and antibodies were produced as previously 
described36.
ATCase is known to be involved in pyrimidine synthesis. ATCase is a cytoplasmic protein that was found to be 
surface exposed37. ATCase (SP_RS06260) was cloned and expressed as a His-tag soluble protein. Briefly, ATCase 
was amplified from the R6 strains using specific primers (Supplementary Table 1, ACTaase gene for pET32a+) 
and ligated into pET32a+ (Novagen, Madison, WI, USA) following digestion with EcoR1 and Xho1 restriction 
enzymes. The plasmid was transformed into DH5α E. coli cells. The vector was purified and transformed into E. 
coli BL21. Sequencing was performed to rule out any mutation. Protein expression was induced by 0.1 mM IPTG 
for 3 h. Following bacterial lysis the protein was purified using NI-NTA column under native condition.
Flow cytometry of S. pneumonia. Flow cytometry was performed as previously described51. Briefly, R6 
bacteria were incubated with mouse anti-rFlaR antibodies or control mouse serum, washed, and stained with 
Alexa Fluor 647®-conjugated goat-anti-mouse-IgG (Jackson ImmunoResearch, West Grove, PA). Flow cytome-
try was performed using a FACSCalibur flow cytometer (Becton Dickinson, Mountain View, CA), and data were 
acquired and analyzed using BD CellQuestTM 3.3 software.
Isolation of S. pneumoniae Cell-Wall (CW) Proteins. CW proteins were isolated by the method of Siegel 
et al.83. Briefly, bacteria were harvested by centrifugation at 4700 g for 15 min, washed with PBS and incubated 
with 3 ml protoplast buffer (20% sucrose, 2.5 mM MgCl2, 5 mM Tris-Cl, pH 7.4), 1000U mutanolysin and 0.2 ml 
protease inhibitor cocktail for 1 h at 37 °C. The soluble proteins released from the cell-wall were collected after 
centrifugation at 25,000 g and stored at −70 °C.
Immunobloting Analysis. Protein mixtures were separated by SDS-PAGE and transferred to nitro-
cellulose membranes (Bio-Rad Laboratories, Inc., Carlsbad, CA), according to manufacturer’s instructions. 
Immunobloting analysis of FlaR expression was performed with rabbit anti-sera obtained against purified rFlaR 
and detected with Cy™3 AffiniPure Donkey Anti-Mouse IgG (H + L) (Jackson ImmunoResearch, West Grove, 
PA).
rFlaR NADP Reductase Assay. The reaction mixture contained 50 µM FAD, 200 µM NADP, 10 µM 
ammonium iron sulfate and 6 µM rFlaR in PBS buffer. NADP reduction was detected by increased absorbance 
at A340 nm, which does not overlap ferrous absorbance at A240 nm, as measured with a BioRad SmartSpec 3000 
Spectrophotometer (Bio Rad; Oceanside, California, USA).
Detection of Iron Binding. The assay was performed as described by Da Lozzo et al.84 with slight modifica-
tions. Briefly, rFlaR (6 µM) was mixed with PBS containing 20 µM ammonium iron sulfate. Ferrozine (50 µM) was 
added to the reaction mixture and absorbance at A562 nm was measured after 10 min. BSA (6 µM), rACTase and 
EDTA (10 nM) were used as negative and positive controls, respectively.
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Ability of Cysteine to Reduce Iron. Freshly prepared solution of 20 µM ammonium iron sulfate in PBS 
was incubated for 2 h at 25 °C to allow Fe2+ oxidation prior to the addition of 5 mM cysteine. The extent of Fe2+ 
oxidation in PBS solution was tested with ferrozine stain, and absorbance monitored at A562 nm. The same manip-
ulations were performed for 200 µM NADP and 50 µM FAD solutions in PBS, and absorbance was measured at 
A340 nm and at A450 nm, respectively.
Bioinformatics Analyses. All completely sequenced genomes of S. pneumoniae were downloaded from 
NCBI’s Genome database (29 genomes as of October 2nd, 2016). The flavin reductase amino acid sequence of the 
TIGR4 strain (WP_000580663.1) was used as a query in tblastn and blastp searches against each of these genomes 
and their predicted proteins. WP_000580663.1 sequence was then used as a query in a blastp search against all 
RefSeq proteins annotated as S. pneumoniae and “flavin reductase”. The 63 retrieved protein hits were subjected to 
multiple sequence alignment using Tcoffee with default parameters. A representative set of 9 divergent proteins 
was selected from the multiple sequence alignment by inspecting a Neighbor Joining tree and choosing a repre-
sentative protein from each clade. Multiple sequence alignment of these proteins was performed using Tcoffee 
and visualized using the Jalview software. Finally, the entire RefSeq protein database except for S. pneumonia 
proteins was searched by blastp with WP_000580663.1 as a query. Only Genbank records containing the word 
“Flavin” and having blastp e value < 0.001 were retrieved.
Preparation of WU2ΔflaR Mutant Bacteria (kanamycin or erythromycin resistance). To create 
null mutants of the flaR gene, the kanamycin (Kan) or erythromycin (Erm) resistance cassette was inserted into 
the coding sequence of flaR via homologous recombination. The transformation procedure was performed as 
previously described85 with minor modifications. The upstream and downstream flanking regions of flaR were 
amplified by PCR from DNA of WU2 strain using the primer combinations upwing-F/upwing-R (Supplementary 
Table S1, Upwing WU2ΔflaR), for the upstream region, and downwing-F/downwing-R, for the downstream 
region (Supplementary Table S1, Downwing WU2ΔflaR). The upwing 1149 bp harbors 125 bp of flaR. The 
downwing 582 bp harbors 68 bp of the flaR. Hence, the expected length of the flaR fragment to be deleted was 
277 bp. The Kan cassette was amplified by PCR from the genome of CP125086 using the primer combinations 
Kan AB-F/Kan AB-R (Supplementary Table S1, Kan AB cassette). The Erm cassette was amplified by PCR from 
the genome of WU2ΔnoxErm52 using the primer combinations Erm AM-F/Erm AM-R (Supplementary Table S1, 
Erm AM cassette). The PCR products were digested with the corresponding restriction nucleases, as specified in 
Supplementary Table S1, purified, ligated and transformed into WU2 in the presence of competence stimulating 
factor, CSP1 and CaCl2. Transformants were selected on THY solidified with 1.5% agar, containing kanamycin 
(80 µg/ml) or erythromycin (125 µg/ml). Verification of flaR deletion was done by PCR using specific primers 
(Supplementary Table S1, Kan AB cassette for Kan resistance and Erm AM cassette for Erm resistance). It is worth 
mentioning that phenotypically, flaR mutation did not affect the size and mucosity of the colonies.
Of note, the kanamycin resistant mutant strain, WU2ΔflaRKan, was used in the mice inoculation studies. The 
erythromycin resistant mutant strain, WU2ΔflaRErm, was used in the susceptibility to oxidative stress experi-
ment and the adhesion to A549 cells assay.
Construction of two WU2ΔflaRflaR/Erm/Kan complemented strains.  Trans-complementation of 
WU2ΔflaRErm. Complementation was performed using Gram positive compatible plasmid, pBAV1K-T5-gfp 
(Addgene; Cambridge, MA), bearing the kanamycin resistance cassette. The flaR gene was amplified from WU2 
genome using flaR- F and flaR-R primers (Supplementary Table S1, flaR pBAV-K1- plasmid and pCEP comple-
mentation), which introduce NcoI and PstI sites. Subsequently the plasmid was digested, resulting in gfp gene 
deletion and retaining the constitutive T5 viral promoter. Following the ligation of flaR to pBAV1K-T5-gfp, the 
plasmid was transformed into E. coli DH5α, overexpressed, purified and transformed into WU2ΔflaRErm to pro-
duce WU2ΔflaRflaR/Erm/Kan complemented strain. Successful insertion of pBAV1K-T5flaR was verified by PCR.
Cis-complementation of WU2ΔflaRErm. To confirm that mutation of flaR in WU2ΔflaRErm introduced no polar 
effects, WU2ΔflaRErm was complemented with an intact copy of the gene using pCEP, which is a nonreplicative 
plasmid that allows controlled gene expression under its native promoter, following ectopic integration into the 
chromosome87,88. Briefly, flaR was amplified from WU2 with flaR- F and flaR-R primers (Supplementary Table S1, 
flaR pBAV-K1- plasmid and pCEP complementation), which introduce NcoI and PstI sites. Then the amplicons 
were ligated into NcoI and PstI digested vector. An aliquot of ligation mixture was transformed into Stellar™ com-
petent cells (Clonetech, Saint-Germain-en-Laye, France) as described by the manufacturer. The transformants 
were selected for kanamycin resistance (500 μg/ml). Successful ligation was determined by colony PCR using 
Mal-F and pCEP-R primers (Supplemental Table S1, flaR pCEP verification), whose recognition sites are local-
ized immediately up and downstream of the cloning site, respectively. These primers amplified 263 bp product in 
empty vector, while they produce a product of 913 bp in the recombinant clones (additional 650 bp represents the 
cloned fragment containing flaR). The recombinant plasmid was purified using a commercial kit (Qiagen), and 
an aliquot was transformed into WU2ΔflaRErm as described previously89 to produce the complemented strain 
WU2ΔflaRflaR/Erm/Kan chromosome. The transformants were selected on blood agar plates supplemented with 
erythromycin (125 μg/ml) and kanamycin (500 μg/ml). Integration of flaR into the genome was confirmed by 
PCR (Supplementary Table S1, Kan resistance in pCEP verification).
Oxidative stress assay. Oxidative stress assays were performed as previously described87 with minor mod-
ifications. Briefly, WU2 WT, WU2ΔflaRErm and WU2ΔflaRflaR/Erm/Kan plasmid and chromosome strains were 
grown under anaerobic conditions in 20 ml of THY medium to an OD620 = 0.3. Five ml of culture were harvested 
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by centrifugation at 4000 rpm for 20 min and resuspended in 5 ml of PBS. Even volumes of the bacteria were dis-
pensed, mixed with equal volumes of either H2O2 (final concentration 20 mM) or PBS and incubated at 37 °C for 
30 min. Following the incubation serial dilutions were plated onto blood agar plates for bacterial enumeration. 
The percent survival was calculated by dividing the CFU of cultures after exposure to H2O2 by the CFU in the 
control culture without H2O2 of the respective strain. The results presented are the average of three independent 
experiments performed in triplicates.
Primary macrophage phagocytosis assay. Mice were injected intraperitoneally with 3% thioglycolate 
broth. Three days later mice were euthanized, using CO2, and their peritoneal cells were harvested by flushing 
the peritoneum with 10 ml of PBS. Cells were centrifuged and resuspended in complete (c) RPMI 1640 medium 
supplemented with 10% FCS and 2% L-glutamine. 2 × 105 cells/well were plated onto 96 well culture plates. The 
macrophages were allowed to adhere for 9 hours and the supernatant was removed. 2.5 × 104 of midlog harvested 
bacteria in RPMI 1640 were added to the well for 40 minutes incubation at 37 °C. Following the incubation, ali-
quots were taken from the supernatant and plated onto blood agar plates for enumeration. The number of residual 
live bacteria CFU was subtracted from the initial bacterial CFU resulting in the number of phagocytosed bacteria. 
The data presented is the summary of 2 biological independent experiments each performed in triplicates.
S. pneumoniae adhesion to A549 cells assay. A549 cells (lung adenocarcinoma cells; ATCC, Rockville, 
MD, USA) retain morphological, biochemical and immunological characteristics resembling type II lung epithe-
lial cells90–92 and have been widely used as a model to study S. pneumoniae interaction with human cells37,51. A549 
cells were cultured on 96-well plates (2.5 × 105 cells/well) in DMEM without antibiotics. Following overnight 
incubation each well contained ~105 A549 cells. WU2 WT, WU2ΔflaRErm and WU2ΔflaRflaR/Erm/Kan strains (~106 
CFU; multiplicity of infection (MOI) 10:1) were added to the cells for 1 hr incubation at 37 °C. Bacteria were 
enumerated after the 1 h incubation and no bacterial death under the experimental conditions could be observed 
in WT, mutant and complemented strains (data not shown). Excess bacteria were removed, and cells detached 
with 0.25% trypsin-EDTA and plated onto blood agar plates for enumeration. This experiments were performed 
in triplicate and repeated three times.
rFlaR elicits antibody response in immunized mice. Mice were immunized with 25 µg rFlaR refolded 
in the presence of 2 mM Fe2+ using CFA in primary immunization and IFA in the following booster immuniza-
tions. Microtiter plates (F96 Maxisorp Nunc (ThermoFisher) were coated with 1 µg/ml solution of rFlaR in bicar-
bonate buffer pH 9.6. Plates were blocked with 2% BSA solution in PBS. Sera obtained from mice immunized 
with rFlaR following each immunization were diluted with PBS and used as the primary antibodies. Washes were 
performed with PBS supplemented with 0.05% tween. Secondary antibody used was HRP conjugated anti-mouse 
IgG (Jackson laboratories). Detection was performed using tetramethylbenzidine (TMB; DakoCytomation) as 
substrate. Reaction was stopped using 1 M H2SO4. Absorbance was determined at 450 nm using ELISA reader 
multimode detector DTX 880 (BECKMAN COULTER). Serum obtained from mice immunized with rPtsA37 
(PtsA IV) was used as a negative control.
Statistical Analysis. The Shapiro-Wilk test was used and post-hoc statistical power was calculated, respec-
tively, to verify that small sample sized data sets assumed normal distribution and are of the sufficient size to 
justify the use of one-way ANOVA for parametric data, followed by the Dunnett’s test for multiple compari-
sons. One-tailed Student’s t-test with Welch’s correction was used for bacterial load comparisons of two groups. 
Data was reported as the mean ± SEM, unless stated otherwise. Pearson and Spearman correlations were used 
to assess the significance of change. Survival of S. pneumoniae-inoculated mice was determined using Log-rank 
(Mantel-Cox) test. Differences were considered significant at p < 0.05. All statistical analyses were performed 
with the software package in GraphPad Prism version 7 (La Jolla, CA, USA).
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